The three largest pharmaceutical distributors — McKesson ($359 billion FY2025 revenue), AmerisourceBergen/Cencora, and Cardinal Health ($222.6 billion FY2025) — collectively distribute approximately 90% of all pharmaceuticals sold in the United States. The drug distribution industry operates on thin margins — typically 0.5-1% of revenue — but generates enormous absolute cash flows from this scale. Drug shortages — driven by generic drug manufacturing concentration in India and China, raw material supply chain vulnerabilities, and economic disincentives to produce low-margin generic sterile injectables — represent the most significant operational and reputational risk facing drug distributors.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.


Topics Covered
• Drug Distribution Market Structure
• McKesson, Cencora, Cardinal Health Competitive Comparison
• Specialty Distribution
• Cold Chain and Temperature-Sensitive Distribution
• Drug Shortage Dynamics
• Last Mile and Retail Pharmacy Distribution
• 3PL Healthcare Logistics